Explore Stanford technologies available for licensing:

Stanford researchers have developed a macrophage-targeted PEGylated liposome ("PEGosome") platform that selectively delivers polyethylene glycol (PEG) to inflammatory monocytes and macrophages driving neuroinflammation in diseases such as multiple sclerosis (MS), Alzheimer's d

Stanford scientists have developed a prolonged drug-releasing formulation for delivering an iron chelation therapeutic to central nervous system in preterm births to prevent post-hemorrhagic hydrocephalus (PHH) in severe neonatal intraventricular hemorrhage (IVH)

A team of Stanford researchers has developed a precisely controlled hydrogel drug delivery system that prevents scarring and promotes wound healing in large, full thickness wounds.